Summarizing a Research Article
Research Question
The research question for the article by Rossi, Barraco and Donda (2004) was based on the fact that there had been no review of the meta-analyses published on Fluoxetine. Fluoxetine is an important drug that was developed for and prescribed to patients with depression starting in the late 1980s. It is considered the first iteration of the generation of Selective Serotonin Re-uptake Inhibitors (SSRIs) commonly associated with youths suffering from mental health problems. However, though it has been widely studied, fluoxetine is still not completely understood. Thus, the authors of this study set out to answer the question: What do the available meta-analyses on this SSRI actually say? The objective of the systematic review of the literature was threefold:
1. to evaluate the strength of the information available in reviewed meta-analyses
2. to understand if the use of fluoxetine is clinically effective and safe compared with previously available drugs
3. to point out the drug's current role in the treatment of diseases where fluoxetine is indicated (Rossi et al., 2004, p. 2).
In short, the authors intended to evaluate whether previous information published on the drug is accurate and reliable; to see if the compile information shows that the drug is safe relative to drugs that had hit the market before; and to see what the use the drug offers in treatments today.
Hypothesis Tested
The authors did not clearly identify a hypothesis that they were testing. However, they did state that upon reviewing the literature on fluoxetine’s effect on treating depression that all the studies confirmed the hypothesis that the drug is more effective at treating depression when given at the lower common dosage of 20 mg/die than at higher dosages (Rossi et al., 2004). Oddly, however, there is no other mention of this hypothesis that is...…was better than other drugs on the market.
Key Implications
Based on the findings of the meta-analysis, the authors imply that fluoxetine is effective at treating depression and is safer than other drugs when it comes to the issue of overdosage. However, the researchers found that the most effective dosage, based on the literature, was the lower one at 20 mg/die. This means that in order to provide the best pharmacological intervention for depressed patients, the dosage should be capped there except for cases in which more is justified.
Conclusion
The study by Rossi et al. (2004) was a qualitative meta-analysis literature review of prior meta-analyses conducted on the drug fluoxetine when comparing its usefulness to a placebo or to other drugs. The analysis found that fluoxetine is safer than other drugs, that its role in today’s health care landscape should still be prominent, and that the studies conducted on the drug were…
Depression, Diabetes and Obesity This is a case study on a 58-year-old male, Mr. H.Y. who worked at a supermarket and is now retired. He has a supportive wife who works full time and children who are all independent .He has a history of smoking, but quit 10 years ago and drinks alcohol twice a week. He is obese and a known case of diabetes for one year. He has gained
Treatments of Bulimia Nervosa THE BEST OPTION Evaluation of Combined Therapy for Bulimia Nervosa Description and Significance Bulimia nervosa, simply bulimia or BN, refers to uncontrolled overeating or binging and then eliminating what has been eaten (SJH, 2012; Grange et al., 2004). Recent reports show alarming increases in the incidence, which now adolescents and pre-adolescents. The latest population statistics say that about 27.3 of the U.S. population is between 12 and 19 years old.
Pharmacology: Moclobemide Moclobemide is classified as an antidepressant, a MAO (monoamine oxidase) inhibitor. Antidepressants are designed to inhibit the reuptake or reabsorbtion of specific neurotransmitters, increasing the levels of these neurotransmitters around the nerves of the brain (Gbemudu, 2011:1). Neurotransmitters such as serotonin, dopamine and norepinephrine (noradrenaline) are often called 'feel good' chemicals that elevate the patient's mood. Drug class A deficit of mood-enhancing chemicals is associated with depression, although there is no
Figure 1 portrays three of the scenes 20/20 presented March 15, 2010. Figure 1: Heather, Rachel, and Unnamed Girl in 20/20 Program (adapted from Stossel, 2010). Statement of the Problem For any individual, the death of a family member, friend, parent or sibling may often be overwhelming. For adolescents, the death of person close to them may prove much more traumatic as it can disrupt adolescent development. Diana Mahoney (2008), with the
Psychopharmacology It was only in the 1950s when psychiatric drugs to treat severe depression were first developed. Prior to that, most people had to suffer with their emotional pain and its attached sigma. Many individuals had to be admitted to mental hospitals. Now, psychiatrists can prescribe any of hundreds of medications for this illness and, in the majority of cases, have successful results. Monoamine Oxidase Inhibitors or MAOs were the first pharmaceuticals
Tom Shulich ("Coltish Hum") A Critical Comparison of Behavior Therapy and Rational-Emotive Therapy In this paper, I consider the benefits and drawbacks of behavior therapy and the cognitive therapy. These are talking therapies that now have over a half-century of application in clinical settings and are still used today in conjunction with, or as an alternative to, drug treatments of psychological disorders. I conclude that these therapies are still useful, though each
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now